Global Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Description

The global Flu Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report studies the global Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Flu Vaccine total production and demand, 2018-2029, (M Doses)
Global Flu Vaccine total production value, 2018-2029, (USD Million)
Global Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (M Doses)
U.S. VS China: Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Doses)
Global Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)
Global Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Doses).

This reports profiles key players in the global Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Flu Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/Doses) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Flu Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Flu Vaccine Market, Segmentation by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Global Flu Vaccine Market, Segmentation by Application
    6 Months to 3 Years
    > 3 Years

Companies Profiled:
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    BCHT
    Jiangsu GDK
    KM Biologics

Key Questions Answered
1. How big is the global Flu Vaccine market?
2. What is the demand of the global Flu Vaccine market?
3. What is the year over year growth of the global Flu Vaccine market?
4. What is the production and production value of the global Flu Vaccine market?
5. Who are the key producers in the global Flu Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Flu Vaccine Introduction
    1.2 World Flu Vaccine Supply & Forecast
        1.2.1 World Flu Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Flu Vaccine Production (2018-2029)
        1.2.3 World Flu Vaccine Pricing Trends (2018-2029)
    1.3 World Flu Vaccine Production by Region (Based on Production Site)
        1.3.1 World Flu Vaccine Production Value by Region (2018-2029)
        1.3.2 World Flu Vaccine Production by Region (2018-2029)
        1.3.3 World Flu Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Flu Vaccine Production (2018-2029)
        1.3.5 Europe Flu Vaccine Production (2018-2029)
        1.3.6 China Flu Vaccine Production (2018-2029)
        1.3.7 Japan Flu Vaccine Production (2018-2029)
        1.3.8 Australia Flu Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Flu Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Flu Vaccine Major Market Trends

2 Demand Summary
    2.1 World Flu Vaccine Demand (2018-2029)
    2.2 World Flu Vaccine Consumption by Region
        2.2.1 World Flu Vaccine Consumption by Region (2018-2023)
        2.2.2 World Flu Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Flu Vaccine Consumption (2018-2029)
    2.4 China Flu Vaccine Consumption (2018-2029)
    2.5 Europe Flu Vaccine Consumption (2018-2029)
    2.6 Japan Flu Vaccine Consumption (2018-2029)
    2.7 South Korea Flu Vaccine Consumption (2018-2029)
    2.8 ASEAN Flu Vaccine Consumption (2018-2029)
    2.9 India Flu Vaccine Consumption (2018-2029)

3 World Flu Vaccine Manufacturers Competitive Analysis
    3.1 World Flu Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Flu Vaccine Production by Manufacturer (2018-2023)
    3.3 World Flu Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Flu Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Flu Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Flu Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Flu Vaccine in 2022
    3.6 Flu Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Flu Vaccine Market: Region Footprint
        3.6.2 Flu Vaccine Market: Company Product Type Footprint
        3.6.3 Flu Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Flu Vaccine Production Value Comparison
        4.1.1 United States VS China: Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Flu Vaccine Production Comparison
        4.2.1 United States VS China: Flu Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Flu Vaccine Consumption Comparison
        4.3.1 United States VS China: Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Flu Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Flu Vaccine Production (2018-2023)
    4.5 China Based Flu Vaccine Manufacturers and Market Share
        4.5.1 China Based Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Flu Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Flu Vaccine Production (2018-2023)
    4.6 Rest of World Based Flu Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Flu Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Flu Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Flu Vaccine Production by Type (2018-2029)
        5.3.2 World Flu Vaccine Production Value by Type (2018-2029)
        5.3.3 World Flu Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 6 Months to 3 Years
        6.2.2 > 3 Years
    6.3 Market Segment by Application
        6.3.1 World Flu Vaccine Production by Application (2018-2029)
        6.3.2 World Flu Vaccine Production Value by Application (2018-2029)
        6.3.3 World Flu Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Flu Vaccine Product and Services
        7.1.4 Sanofi Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Flu Vaccine Product and Services
        7.2.4 CSL Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Flu Vaccine Product and Services
        7.3.4 GSK Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Flu Vaccine Product and Services
        7.4.4 Viatris Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Flu Vaccine Product and Services
        7.5.4 AstraZeneca Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Hualan Bio
        7.6.1 Hualan Bio Details
        7.6.2 Hualan Bio Major Business
        7.6.3 Hualan Bio Flu Vaccine Product and Services
        7.6.4 Hualan Bio Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Hualan Bio Recent Developments/Updates
        7.6.6 Hualan Bio Competitive Strengths & Weaknesses
    7.7 Changchun Institute of Biological
        7.7.1 Changchun Institute of Biological Details
        7.7.2 Changchun Institute of Biological Major Business
        7.7.3 Changchun Institute of Biological Flu Vaccine Product and Services
        7.7.4 Changchun Institute of Biological Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Changchun Institute of Biological Recent Developments/Updates
        7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.8 Sinovac
        7.8.1 Sinovac Details
        7.8.2 Sinovac Major Business
        7.8.3 Sinovac Flu Vaccine Product and Services
        7.8.4 Sinovac Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Sinovac Recent Developments/Updates
        7.8.6 Sinovac Competitive Strengths & Weaknesses
    7.9 BCHT
        7.9.1 BCHT Details
        7.9.2 BCHT Major Business
        7.9.3 BCHT Flu Vaccine Product and Services
        7.9.4 BCHT Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 BCHT Recent Developments/Updates
        7.9.6 BCHT Competitive Strengths & Weaknesses
    7.10 Jiangsu GDK
        7.10.1 Jiangsu GDK Details
        7.10.2 Jiangsu GDK Major Business
        7.10.3 Jiangsu GDK Flu Vaccine Product and Services
        7.10.4 Jiangsu GDK Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Jiangsu GDK Recent Developments/Updates
        7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.11 KM Biologics
        7.11.1 KM Biologics Details
        7.11.2 KM Biologics Major Business
        7.11.3 KM Biologics Flu Vaccine Product and Services
        7.11.4 KM Biologics Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 KM Biologics Recent Developments/Updates
        7.11.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Flu Vaccine Industry Chain
    8.2 Flu Vaccine Upstream Analysis
        8.2.1 Flu Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Flu Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Flu Vaccine Production Mode
    8.6 Flu Vaccine Procurement Model
    8.7 Flu Vaccine Industry Sales Model and Sales Channels
        8.7.1 Flu Vaccine Sales Model
        8.7.2 Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Flu Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Flu Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Flu Vaccine Production by Region (2018-2023) & (M Doses)
    Table 7. World Flu Vaccine Production by Region (2024-2029) & (M Doses)
    Table 8. World Flu Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Flu Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Flu Vaccine Average Price by Region (2018-2023) & (USD/Doses)
    Table 11. World Flu Vaccine Average Price by Region (2024-2029) & (USD/Doses)
    Table 12. Flu Vaccine Major Market Trends
    Table 13. World Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Doses)
    Table 14. World Flu Vaccine Consumption by Region (2018-2023) & (M Doses)
    Table 15. World Flu Vaccine Consumption Forecast by Region (2024-2029) & (M Doses)
    Table 16. World Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Flu Vaccine Producers in 2022
    Table 18. World Flu Vaccine Production by Manufacturer (2018-2023) & (M Doses)
    Table 19. Production Market Share of Key Flu Vaccine Producers in 2022
    Table 20. World Flu Vaccine Average Price by Manufacturer (2018-2023) & (USD/Doses)
    Table 21. Global Flu Vaccine Company Evaluation Quadrant
    Table 22. World Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Flu Vaccine Production Site of Key Manufacturer
    Table 24. Flu Vaccine Market: Company Product Type Footprint
    Table 25. Flu Vaccine Market: Company Product Application Footprint
    Table 26. Flu Vaccine Competitive Factors
    Table 27. Flu Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Flu Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Doses)
    Table 31. United States VS China Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Doses)
    Table 32. United States Based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Flu Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Flu Vaccine Production (2018-2023) & (M Doses)
    Table 36. United States Based Manufacturers Flu Vaccine Production Market Share (2018-2023)
    Table 37. China Based Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Flu Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Flu Vaccine Production (2018-2023) & (M Doses)
    Table 41. China Based Manufacturers Flu Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Flu Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Flu Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Flu Vaccine Production (2018-2023) & (M Doses)
    Table 46. Rest of World Based Manufacturers Flu Vaccine Production Market Share (2018-2023)
    Table 47. World Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Flu Vaccine Production by Type (2018-2023) & (M Doses)
    Table 49. World Flu Vaccine Production by Type (2024-2029) & (M Doses)
    Table 50. World Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Flu Vaccine Average Price by Type (2018-2023) & (USD/Doses)
    Table 53. World Flu Vaccine Average Price by Type (2024-2029) & (USD/Doses)
    Table 54. World Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Flu Vaccine Production by Application (2018-2023) & (M Doses)
    Table 56. World Flu Vaccine Production by Application (2024-2029) & (M Doses)
    Table 57. World Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Flu Vaccine Average Price by Application (2018-2023) & (USD/Doses)
    Table 60. World Flu Vaccine Average Price by Application (2024-2029) & (USD/Doses)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Flu Vaccine Product and Services
    Table 64. Sanofi Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Flu Vaccine Product and Services
    Table 70. CSL Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Flu Vaccine Product and Services
    Table 76. GSK Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Flu Vaccine Product and Services
    Table 82. Viatris Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. AstraZeneca Major Business
    Table 87. AstraZeneca Flu Vaccine Product and Services
    Table 88. AstraZeneca Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. AstraZeneca Recent Developments/Updates
    Table 90. AstraZeneca Competitive Strengths & Weaknesses
    Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 92. Hualan Bio Major Business
    Table 93. Hualan Bio Flu Vaccine Product and Services
    Table 94. Hualan Bio Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Hualan Bio Recent Developments/Updates
    Table 96. Hualan Bio Competitive Strengths & Weaknesses
    Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 98. Changchun Institute of Biological Major Business
    Table 99. Changchun Institute of Biological Flu Vaccine Product and Services
    Table 100. Changchun Institute of Biological Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Changchun Institute of Biological Recent Developments/Updates
    Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 104. Sinovac Major Business
    Table 105. Sinovac Flu Vaccine Product and Services
    Table 106. Sinovac Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Sinovac Recent Developments/Updates
    Table 108. Sinovac Competitive Strengths & Weaknesses
    Table 109. BCHT Basic Information, Manufacturing Base and Competitors
    Table 110. BCHT Major Business
    Table 111. BCHT Flu Vaccine Product and Services
    Table 112. BCHT Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. BCHT Recent Developments/Updates
    Table 114. BCHT Competitive Strengths & Weaknesses
    Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 116. Jiangsu GDK Major Business
    Table 117. Jiangsu GDK Flu Vaccine Product and Services
    Table 118. Jiangsu GDK Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Jiangsu GDK Recent Developments/Updates
    Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 121. KM Biologics Major Business
    Table 122. KM Biologics Flu Vaccine Product and Services
    Table 123. KM Biologics Flu Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Flu Vaccine Upstream (Raw Materials)
    Table 125. Flu Vaccine Typical Customers
    Table 126. Flu Vaccine Typical Distributors
List of Figure
    Figure 1. Flu Vaccine Picture
    Figure 2. World Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 5. World Flu Vaccine Average Price (2018-2029) & (USD/Doses)
    Figure 6. World Flu Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Flu Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 9. Europe Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 10. China Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 11. Japan Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 12. Australia Flu Vaccine Production (2018-2029) & (M Doses)
    Figure 13. Flu Vaccine Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 16. World Flu Vaccine Consumption Market Share by Region (2018-2029)
    Figure 17. United States Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 18. China Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 19. Europe Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 20. Japan Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 21. South Korea Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 22. ASEAN Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 23. India Flu Vaccine Consumption (2018-2029) & (M Doses)
    Figure 24. Producer Shipments of Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Flu Vaccine Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Flu Vaccine Markets in 2022
    Figure 27. United States VS China: Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States VS China: Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 30. United States Based Manufacturers Flu Vaccine Production Market Share 2022
    Figure 31. China Based Manufacturers Flu Vaccine Production Market Share 2022
    Figure 32. Rest of World Based Manufacturers Flu Vaccine Production Market Share 2022
    Figure 33. World Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 34. World Flu Vaccine Production Value Market Share by Type in 2022
    Figure 35. Trivalent Influenza Vaccine
    Figure 36. Quadrivalent Influenza Vaccine
    Figure 37. World Flu Vaccine Production Market Share by Type (2018-2029)
    Figure 38. World Flu Vaccine Production Value Market Share by Type (2018-2029)
    Figure 39. World Flu Vaccine Average Price by Type (2018-2029) & (USD/Doses)
    Figure 40. World Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Flu Vaccine Production Value Market Share by Application in 2022
    Figure 42. 6 Months to 3 Years
    Figure 43. > 3 Years
    Figure 44. World Flu Vaccine Production Market Share by Application (2018-2029)
    Figure 45. World Flu Vaccine Production Value Market Share by Application (2018-2029)
    Figure 46. World Flu Vaccine Average Price by Application (2018-2029) & (USD/Doses)
    Figure 47. Flu Vaccine Industry Chain
    Figure 48. Flu Vaccine Procurement Model
    Figure 49. Flu Vaccine Sales Model
    Figure 50. Flu Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics